drugset / Trial / NCT01197833

Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities

NCT01197833

Phase 3 Completed 117 enrolled Boston Scientific Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and may cause discomfort. In this study, patients with varicose veins in the legs will be participating. The purpose of this research study is to evaluate the safety and effectiveness of two different doses of an investigational drug, Polidocanol Endovenous Microfoam (PEM) compared to vehicle (inactive solution) when used following an approved heat treatment in subjects with varicose veins.

Timeline

Start
2010-09
Primary completion
2012-03
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Polidocanol Other / unclassified 0.125 % Other
Subject Polidocanol Other / unclassified 1 % Other